IsoRay’s Cancer Fighting Isotope Cesium-131 Will Be Featured in Four Oral Presentations at the American Brachytherapy Society (ABS) Convention in Orlando, Florida
Presentations Include Long-Term Selected Side Effect Data for Prostate Cancer; FMEA Quality Assessment for Head and Neck Cancer Utilizing Cesium-131; Primary Management of Gynecologic Malignancies With Cesium-131; and Permanent Brain Brachytherapy Treatment Planning Using Stranded Cesium-131 Seeds […]